Blueprint Medicines Corp (BPMC) Insider Trading

Total insider buys:
  • $348,278.00
Total insider sells:
  • $177,560,027.15
Most recent insider trade:
  • March 24, 2025
Most active insider trader:
  • Jeffrey W Albers
Trader NameDateTitleAmountPriceTypeTotal Value
March 6, 2023CEO6,640$45.69Sell$303,381.60
March 6, 2023Director9,793$45.67Sell$447,246.31
Dec. 5, 2022Director20,000$50.09Sell$1,001,800.00
Nov. 3, 2022COO533$45.24Sell$24,112.92
Nov. 3, 2022CEO1,100$43.98Buy$48,378.00
Oct. 4, 2022Insider3,477$67.30Sell$234,002.10
Aug. 24, 2022Insider5,000$75.11Sell$375,550.00
Aug. 22, 2022Director8,410$70.54Sell$593,241.40
Aug. 19, 2022Director1,590$70.02Sell$111,331.80
Aug. 16, 2022Director20,000$68.41Sell$1,368,200.00
Aug. 8, 2022Director10,000$70.07Sell$700,700.00
Aug. 4, 2022SVP2,500$60.44Sell$151,100.00
June 6, 2022Insider1,908$59.76Sell$114,022.08
April 6, 2022CEO5,000$70.11Sell$350,550.00
March 16, 2022Insider2,219$60.00Sell$133,140.00
March 10, 2022Insider2,339$57.15Sell$133,673.85
March 7, 2022Insider256$56.19Sell$14,384.64
March 3, 2022Insider761$60.27Sell$45,865.47
March 3, 2022Director5,000$59.98Buy$299,900.00
Dec. 15, 2021Insider729$100.00Sell$72,900.00
Dec. 13, 2021COO1,000$98.30Sell$98,300.00
Dec. 7, 2021EVP5,000$97.30Sell$486,500.00
Nov. 15, 2021CEO30,000$114.50Sell$3,435,000.00
Nov. 15, 2021Insider729$115.49Sell$84,192.21
Nov. 3, 2021EVP5,000$110.56Sell$552,800.00
Oct. 15, 2021Insider729$102.66Sell$74,839.14
Oct. 5, 2021Insider3,241$98.18Sell$318,201.38
Sept. 23, 2021EVP25,000$108.85Sell$2,721,250.00
Sept. 23, 2021Insider600$110.00Sell$66,000.00
Aug. 19, 2021CEO25,000$92.68Sell$2,317,000.00
Aug. 17, 2021Insider1,350$91.93Sell$124,105.50
June 28, 2021COO1,000$90.24Sell$90,240.00
May 12, 2021CEO25,000$92.69Sell$2,317,250.00
Jan. 4, 2021Director758$112.15Sell$85,009.70
Dec. 24, 2020Director5,455$125.00Sell$681,875.00
Dec. 17, 2020Director10,909$117.82Sell$1,285,298.38
Dec. 1, 2020Director5,454$110.00Sell$599,940.00
Nov. 3, 2020Insider345$99.69Sell$34,393.05
Oct. 16, 2020COO13,334$101.23Sell$1,349,800.82
Oct. 7, 2020Director5,454$100.00Sell$545,400.00
Oct. 7, 2020Insider600$100.00Sell$60,000.00
Oct. 7, 2020CEO5,000$99.17Sell$495,850.00
Sept. 22, 2020Director1,704$85.00Sell$144,840.00
Sept. 22, 2020Insider6,864$82.33Sell$565,113.12
Sept. 22, 2020COO3,143$85.49Sell$268,695.07
Sept. 17, 2020Director500$80.00Sell$40,000.00
Sept. 17, 2020Insider23,136$80.00Sell$1,850,880.00
Aug. 17, 2020Insider700$75.00Sell$52,500.00
July 6, 2020Director26,007$80.45Sell$2,092,263.15
July 2, 2020Director4,125$80.16Sell$330,660.00
  • Insiders are both buying and selling Blueprint Medicines Corp stock.

  • The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Christina Rossi, Daniel Lynch, L. Becker Hewes, Christopher K Murray, George Demetri, Nicholas Lydon, Marion Dorsch, Debra Durso-Bumpus, Anthony L Boral, Tracey L Mccain, Fmr Llc, Michael Landsittel, Christoph Lengauer, Mark Alan Goldberg, Fouad Namouni, Percy H Carter, Charles A Rowland Jr, Rock Ventures Ii L.P. Third, Kevin P. Starr, Lonnel Coats, Mark J Levin, Alexis Borisy, and Philina Lee

  • The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 41 trades.

  • Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.

  • Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.

  • The most recent insider trade for Blueprint Medicines Corp was on March 24, 2025.

  • The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.

  • The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.